The Anger Treatment Program: An Intervention for Adults with Mental Retardation

描述(申请人提供)：具有挑战性的行为，主要是愤怒和攻击性，在智力障碍(MR)患者的生活中所起的作用对他们的福祉和他们在社区环境中的成功融入构成威胁。精神分裂症患者的愤怒患病率明显高于普通人群，对这些行为的低容忍度对教育、居住和职业安置产生了负面影响。鉴于精神分裂症患者的愤怒问题发生率很高，以及它对自己的生活和支持他们的人的生活产生的负面影响，我们必须解决这种情况。这个项目的总体目标是开发和评估一种基于研究的治疗方案，为支持提供者提供一套交互式多媒体(IMM)工具，以促进在愤怒管理领域与患有MR的个人的合作。治疗方案将基于Novaco的压力接种方法来管理愤怒。第一阶段的目标是为前四次会议制定材料和协议，包括愤怒治疗计划(ATP)的准备阶段。一项可行性研究将评估该计划的实用性、有效性和消费者对该计划的接受度，样本包括25名患有轻度MR的人，这些人被确认为有愤怒管理问题，以及这些人居住的支持提供者。第一阶段的积极成果将证明支持第二阶段申请的充分可行性。在第二阶段，将开发12个疗程的ATP治疗阶段。由此产生的综合IMM教学计划将为支持提供者提供必要的知识和技能，以实施基于证据的愤怒管理方法，以满足MR患者的需求。该项目将第一次对社区环境中有严重但非慢性和普遍愤怒问题的MR患者实施压力接种愤怒管理方法，并利用支持提供者提供干预。该项目解决了MR患者的攻击性和愤怒问题，这是一个重大的公共卫生问题。针对患有MR的个人的愤怒管理计划可以减少他们愤怒问题导致的不利心理和身体健康后果，并减少支持提供者的压力和职业倦怠。

DESCRIPTION (provided by applicant): The role of challenging behaviors, primarily anger and aggression, in the lives of people with mental retardation (MR) poses a threat to their well-being and to their successful integration in community settings. The prevalence of anger among individuals with MR is remarkably higher than among the general population, and low tolerance of these behaviors negatively impacts educational, residential, and vocational placements. Given the high incidence of anger problems among individuals with MR and its negative effect on their own lives and the lives of those who support them, it is imperative that we address the situation. The overall goal of this project is to develop and assess a research-based treatment protocol that gives support providers a set of interactive multimedia (IMM) tools to facilitate work with individuals who have MR in the area of anger management. The treatment protocol will be based on Novaco's stress inoculation approach to anger management. The Phase I goals are to develop materials and protocols for the first four sessions, comprising the preparatory phase of the Anger Treatment Program (ATP). A feasibility study will evaluate the utility, effectiveness and consumer acceptance of the program with a sample of 25 dyads including individuals with mild MR identified as having anger management problems, and support providers in residences of these individuals. Positive outcomes in Phase I will demonstrate sufficient feasibility in support of a Phase II application. In Phase II, the 12-session treatment phase of the ATP will be developed. The resulting comprehensive IMM instructional program will provide support providers with the necessary knowledge and skills to implement an evidence-based anger management approach to meet the needs of people with MR. This project will be the first to implement the stress-inoculation anger management approach to individuals with MR who have significant but not chronic and pervasive anger problems in community settings, and to utilize support providers to deliver the intervention. The project addresses the problem of aggression and anger in people with MR, a significant public health concern. An anger management program for individuals who have MR could reduce the adverse psychological and physical health consequences that result from their anger problems and lead to a reduction in stress and burnout among support providers.